» Articles » PMID: 15944058

Drugs in Injured Drivers in Denmark

Overview
Specialty Forensic Sciences
Date 2005 Jun 10
PMID 15944058
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

As part of the project Impaired Motorists, Methods of Roadside Testing and Assessment for Licensing (IMMORTAL) under the European Commission's Transport RTD Programme of the 5th Framework Programme [I.M. Bernhoft, Drugs in accidents involved drivers in Denmark, D-R4.3 of the project Impaired Motorists, Methods Of Roadside Testing and Assessment for Licensing (IMMORTAL), , 2005], a study regarding drugs in accident-involved drivers was carried out in Denmark. The main objectives of this study were: (1) to collect and analyse samples from injured drivers for the presence of drugs; (2) to give an indication whether drugs may have contributed to traffic accidents; and (3) to get information on the drug-positive drivers and their drug use. This paper focuses on objective 1. Injured drivers who were treated in hospital were asked to give a saliva sample, a blood sample or both. The samples were screened for the following substances: opiates, amphetamines, methamphetamines, incl. MDMA (ecstasy), cannabinoids and metabolites, cocaine and metabolites and benzodiazepines. Screenings were carried out by means of Cozart Microplate EIA kit. Positive screenings were confirmation analysed by gas chromatography-mass spectrometry (GC-MS) or liquid chromatography/tandem mass spectrometry (LC/MS/MS). In total, 26 out of 330 patients were confirmed positive for one or more of the six drug groups. However, three patients were excluded from the survey for various reasons. Of the remaining 23 drug-positive patients 15 were found positive for one drug group, and in five of these cases alcohol was present in a concentration over the legal limit in Denmark (0.05%). The other eight patients were found positive for two drug groups, and in four of these cases, alcohol was also present in a concentration over the legal limit. Alcohol was found both in combinations with medicinal drugs, with illegal drugs and with both. Based on the saliva or blood concentrations, we estimate that there is a strong suspicion of impairment in 9 out of 23 cases, and in another six cases it was likely that the drivers were impaired.

Citing Articles

A scoping review of motor vehicle operator performance assessments for benzodiazepine receptor agonists.

Murphy A, Sawires K, Peltekian S, Helwig M, Macdonald M, Martin-Misener R Explor Res Clin Soc Pharm. 2024; 16:100538.

PMID: 39634377 PMC: 11615539. DOI: 10.1016/j.rcsop.2024.100538.


The prevalence of substance use among drivers with traffic injuries in Mazandaran Province, Northern Iran.

Goli Khatir I, Shayesteh Azar M, Zakariaei Z, Rezaee Rad H, Rasouli K Ann Med Surg (Lond). 2022; 82:104768.

PMID: 36268435 PMC: 9577827. DOI: 10.1016/j.amsu.2022.104768.


Development and Validation of Questionnaires on Professional Drivers' Knowledge and Attitudes About Various Medications' Influence on Driving Ability.

Antonic R, Jankovic S, Folic M Zdr Varst. 2022; 61(1):32-39.

PMID: 35111264 PMC: 8776291. DOI: 10.2478/sjph-2022-0006.


Occupational health and safety of road haulage company employees.

Riva M, Cantamessa F, Borleri D, Mosconi G Med Lav. 2018; 109(3):180-9.

PMID: 29943749 PMC: 7689798. DOI: 10.23749/mdl.v109i3.6827.


Oral fluid testing for drugs of abuse.

Bosker W, Huestis M Clin Chem. 2009; 55(11):1910-31.

PMID: 19745062 PMC: 3165054. DOI: 10.1373/clinchem.2008.108670.